Avocado Consumption, Nutrients in Human Milk, and Infant Cognitive Development
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Jan 5, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how eating avocados can benefit breastfeeding mothers and their infants, particularly in terms of brain development. Specifically, the study aims to see if mothers can eat five avocados a week for 12 weeks and how this affects the nutrients in their breast milk, like choline and lutein, which are important for a baby's brain. Additionally, researchers will compare the cognitive skills of infants whose mothers consume avocados with those whose mothers do not.
To participate in the study, mothers must be healthy, breastfeeding, and around 13 weeks postpartum, planning to exclusively breastfeed for the first six months. They will receive avocados every two weeks and will be asked to eat one avocado daily. Researchers will check the infants' cognitive development at 4.5 and 6 months old and will collect breast milk samples and dietary information throughout the trial. This study is currently recruiting participants, and it’s important to note that mothers with certain health issues or family allergies may not be eligible.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • Healthy lactating women at 13 weeks postpartum
- • Planning to exclusively breastfeed to 6 months of age
- • Gave birth at 38 weeks or greater gestation without remarkable incident
- • Pre-pregnancy BMI \<30
- • Exclusion Criteria
- • Gestational diabetes
- • Infant with diagnosis or documented suspicion of developmental delay
- • Any documented seizure activity in infant
- • Family history of avocado, latex, or banana allergies
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kannapolis, North Carolina, United States
Patients applied
Trial Officials
Carol L Cheatham, Ph.D.
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported